CNTX-4975
Sponsors
Centrexion Therapeutics
Conditions
Morton's NeuromaOsteoarthritisOsteoarthritis of the KneePainful Intermetatarsal Neuroma (Morton's Neuroma)
Phase 2
Safety and Tolerability of 4975 in the Treatment of Moderate to Severe Knee Pain Due to Osteoarthritis (OA)
CompletedNCT00667654
Start: 2007-08-31End: 2016-08-31Updated: 2016-12-06
A Study to Evaluate the Efficacy and Safety of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
CompletedNCT02283957
Start: 2014-10-31End: 2016-06-30Updated: 2016-12-06
Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Chronic, Moderate to Severe Osteoarthritis Knee Pain
CompletedNCT02558439
Start: 2015-08-31End: 2017-02-28Updated: 2017-08-08
A Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)
CompletedNCT02678793
Start: 2015-12-31End: 2017-03-31Updated: 2018-05-09